Mounjaro — Before & After

Dual GLP-1 / GIP receptor agonist with strong weight-loss data.

Reference image

Real mounjaro photos coming soon

We're curating consented, licensed before-and-after images for Mounjaro. Until they're live, this page covers the technique, recovery, cost, and what to expect.

Are you a surgeon? Submit your workTry Mounjaro on yourself in Mirrorr AI →

What is mounjaro?

Dual GLP-1 / GIP receptor agonist with strong weight-loss data.

Also known as tirzepatide.

Mounjaro by topic

Information pages — cost, recovery, surgeons, and more

Topic
CostRecoveryRisksCandidatesSurgeonsNear meWhat is it

Mounjaro by recovery timeline

How the result evolves over time

Recovery timeline
1 week2 weeks1 month3 months6 months1 year5 years

Mounjaro by demographic

Age and gender breakdowns of common candidates

Demographic
MenWomen20s30s40s50s60+Teens

Mounjaro by ethnicity

Anatomical and aesthetic considerations across patient backgrounds

Ethnicity
AsianKoreanJapaneseChineseBlackHispanicMiddle EasternIndianCaucasian

Mounjaro by outcome reality

Range of results — from natural to cautionary

Outcome reality
NaturalSubtleDramaticSwellingBruisingHealingRevisionBotched

Mounjaro by where it's performed

Regional approaches and aesthetic preferences

Where it's performed
TurkeyKoreaBrazilMexicoThailandColombiaMiamiLANYCLondonDubaiBeverly HillsHoustonDallasFriscoAtlantaChicagoSFTorontoSydney

Frequently asked

How much weight can you lose on Mounjaro?

In trials (SURMOUNT-1), tirzepatide produced an average 22% body weight loss at 72 weeks at the highest dose. This is the highest weight-loss efficacy of any FDA-approved medication to date.

What's the difference between Mounjaro and Zepbound?

Same molecule (tirzepatide), different FDA-approved indications. Mounjaro is approved for type 2 diabetes; Zepbound is approved for chronic weight management. Identical drug, identical dose options. Insurance coverage can differ dramatically depending on which is prescribed.

Mounjaro vs. Ozempic — which works better?

Tirzepatide outperformed semaglutide in head-to-head trials (~22% vs ~15% body weight loss). Tirzepatide also tends to be better tolerated by some patients. Insurance coverage and provider experience often dictate which a patient ends up on.

How long can you stay on Mounjaro?

Indefinitely if tolerated. Discontinuation typically results in 60%+ weight regain within a year without significant lifestyle change. GLP-1/GIP medications are now generally considered chronic therapy, not short-term tools.

What are Mounjaro side effects?

Nausea, vomiting, constipation, and diarrhea are most common — usually subside within 8 weeks. Pancreatitis and gallbladder disease are rare but serious. Muscle loss is common without protein and resistance training. Boxed warning for thyroid C-cell tumors is theoretical.